Aditxt (ADTX) Cash from Operations (2019 - 2026)
Aditxt (ADTX) recorded quarterly Cash from Operations of 4578712.0 in Q1 2026, up 50.48% quarter-over-quarter from 9245673.0 in Q4 2025, and up 60.91% on a YoY basis from 2845502.99 in Q1 2025.
Aditxt (ADTX) Cash from Operations (2019 - 2026) Analysis & Trends
Aditxt's Cash from Operations history runs 8 years deep, the most recent figure standing at 4578712.0 for Q1 2026.
- In Q1 2026, Cash from Operations rose 60.91% year-over-year to 4578712.0; the TTM figure through Mar 2026 stood at 18553676.0 (up 17.59% YoY), while the FY2025 annual figure was 25688359.0, down 53.25% from the prior year.
- Cash from Operations was 4578712.0 for Q1 2026 at Aditxt, up from 9245673.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2289876.0 in Q2 2024 to a low of 11713395.0 in Q1 2025.
- Historically, Cash from Operations has averaged 5213227.35 across 5 years, with a median of 4578712.0 in 2026.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations soared 70.57% in 2024, then plunged 96.5% in 2025.
- A 5-year view of Cash from Operations shows it stood at 6719974.0 in 2022, then surged by 41.43% to 3936117.0 in 2023, then slumped by 56.17% to 6146990.0 in 2024, then sank by 50.41% to 9245673.0 in 2025, then jumped by 50.48% to 4578712.0 in 2026.
- The last three Cash from Operations figures came in at 4578712.0 (Q1 2026), 9245673.0 (Q4 2025), and 2344554.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Aditxt | 2,485.68 | -2.16 Mn | 2,868.00 | -4.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.58 Mn |
| Mar 31, 2026 | -4.58 Mn |
| Dec 31, 2025 | -9.25 Mn |
| Dec 31, 2025 | -9.25 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -2.38 Mn |
| Mar 31, 2025 | -11.71 Mn |
| Mar 31, 2025 | -11.71 Mn |
| Dec 31, 2024 | -6.15 Mn |
| Dec 31, 2024 | -6.15 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Sep 30, 2024 | -2.36 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Jun 30, 2024 | -2.29 Mn |
| Mar 31, 2024 | -5.96 Mn |
| Mar 31, 2024 | -5.96 Mn |
| Dec 31, 2023 | -3.94 Mn |
| Dec 31, 2023 | -3.94 Mn |